Insider Trading News

Idexx Laboratories Inc director Daniel M. Junius sells $844,889 of stock, cutting stake 34%

By Insider Stock Trader Newsroom2 min readInsider Stock Trader
Idexx Laboratories Inc director Daniel M. Junius sells $844,889 of stock, cutting stake 34%Idexx Laboratories Inc director Daniel M. Junius sells $844,889 of stock, cutting stake 34%

The sale reduces the insider's holding by 34%, the filing shows. Information only, not investment advice.

Daniel M. Junius sold about $840,000 of Idexx Laboratories Inc (IDXX) stock on Nov 4, according to an SEC filing. The director received an average of $704.07 for 1,200 shares.

The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. The insider still holds 2,361 shares after the sale, 34% fewer than before.

Four Idexx Laboratories Inc insiders sold on the open market within 14 days, a pattern known as a cluster sell. The trade was reported within two business days, as Section 16 requires.

Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.

The sale
CompanyIdexx Laboratories Inc (IDXX)
InsiderDaniel M. Junius
RoleDirector
TransactionOpen-market sale (code S)
Shares1,200
Average price$704.07
Value$844,889
Trade dateNov 4, 2026
Filed with the SECNov 5, 2026, 5:01 PM ET
Shares held after2,361
OwnershipDirect
Rule 10b5-1 planNot marked in the filing

See more details on this insider sale

View the Form 4 on SEC.gov

See all insider activity at Idexx Laboratories Inc · See all the latest insider trades

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.